By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Science Briefing

Medicine

Science Briefing

Last updated: June 20, 2026 7:02 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE
[SUBJECT here]
Dual-Active Ingredient Nets Reduce Malaria Cases in Pyrethroid-Resistant Ghana


Medicine · Public Health

A Bayesian interrupted time-series analysis assessed the impact of distributing dual-active ingredient Interceptor® G2 insecticide-treated nets (ITNs) on malaria cases in Ghana’s Western North Region, an area with confirmed pyrethroid resistance. The study found an immediate 30% reduction in malaria cases (OR 0.696; CrI 0.623–0.778) post-distribution in 2021, with sustained reductions of 26% at 6 months and 40% at 30 months, controlling for climatic factors. For you, working at the intersection of chronic disease, health behavior, and prevention, this provides powerful, real-world evidence for a scalable public health intervention that can dramatically alter disease risk trajectories in high-burden settings.

Novelty: 88%

Rigor: 92%

Significance: 90%

Validity: 89%

Clarity: 85%


Read the paper →



Update Your Briefing Preferences

Stay curious. Stay informed —

Science Briefing

Your briefing is personalized based on your selected fields, keywords, and research interests.

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Science Briefing
Next Article Science Briefing
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Rituximab offers a new therapeutic avenue for IgA vasculitis

Today’s Neurology Science Briefing | April 15th 2026, 9:00:12 am

Today’s Neurology Science Briefing | March 30th 2026, 1:00:02 pm

Astrocytes’ sugar stash: A new metabolic target for fighting tauopathies

Science Briefing

Today’s Diabetes Science Briefing | April 25th 2026, 9:00:12 am

A Multisectoral Approach to Tackling Gender-Based Violence in Italy

Science Briefing

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?